{"nct_id":"NCT05047185","title":"Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2022-04-19","start_date_type":"ACTUAL","primary_completion_date":"2025-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PHVS"]}